Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma

被引：0
|
作者：
Taku Naiki
Noriyasu Kawai
Yoshihiro Hashimoto
Takehiko Okamura
Ryosuke Ando
Takahiro Yasui
Atsushi Okada
Toshiki Etani
Keiichi Tozawa
Kenjiro Kohri
机构：
[1] Nagoya City University,Department of Nephro
[2] Anjo Kosei Hospital,urology, Graduate School of Medical Sciences
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Metastasis; Urothelial carcinoma; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：516 / 522
页数：6
相关论文
共 50 条
  • [41] Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer
    Cucevic, B
    Samarzija, M
    Baricevic, D
    Jakopovic, M
    Redzepi, G
    Samija, M
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 583 - 588
  • [42] Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma
    Yuji Takeyama
    Minoru Kato
    Chikako Nishihara
    Takeshi Yamasaki
    Taro Iguchi
    Satoshi Tamada
    Katsuyuki Kuratsukuri
    Tatsuya Nakatani
    International Journal of Clinical Oncology, 2018, 23 : 944 - 950
  • [43] DOCETAXEL-GEMCITABINE AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED GASTRIC CANCER
    D'Alessio, Andrea
    Amato, Maria Grazia
    Resta, Davide
    Sbarufatti, Antonio
    Tacchini, Laura
    Venturi, Cristina
    Visacarra, Cecilia
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma
    Takeyama, Yuji
    Kato, Minoru
    Nishihara, Chikako
    Yamasaki, Takeshi
    Iguchi, Taro
    Tamada, Satoshi
    Kuratsukuri, Katsuyuki
    Nakatani, Tatsuya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 944 - 950
  • [45] Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin
    Saito, Kazutaka
    Urakami, Shinji
    Komai, Yoshinobu
    Yasuda, Yosuke
    Kubo, Yuichi
    Kitsukawa, Shinichi
    Okubo, Yuhei
    Yamamoto, Shinya
    Yonese, Junji
    Fukui, Iwao
    BJU INTERNATIONAL, 2012, 110 (10) : 1478 - 1484
  • [46] Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model
    Salah, Samer
    Lee, Jae-Lyun
    Rozzi, Antonio
    Kitamura, Hiroshi
    Matsumoto, Kazumasa
    Srinivas, Sandy
    Morales-Barrera, Rafael
    Carles, Joan
    Al-Wardat, Rami
    Al-Rabi, Kamal
    Maakoseh, Mohammad
    CLINICAL GENITOURINARY CANCER, 2016, 14 (03) : 255 - 260
  • [47] Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study
    Lin, Chia-Chi
    Hsu, Chih-Hung
    Huang, Chao-Yuan
    Keng, Hsiao-Yi
    Tsai, Yu-Chieh
    Huang, Kuo-How
    Cheng, Ann-Lii
    Pu, Yeong-Shiau
    ANTI-CANCER DRUGS, 2007, 18 (04) : 487 - 491
  • [48] Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
    Lee, Jung Hyun
    Kang, Sung Gu
    Kim, Seung Tae
    Kang, Seok Ho
    Choi, In Keun
    Park, Young Je
    Oh, Sang Chul
    Sung, Deuk Jae
    Seo, Jae Hong
    Cheon, Jun
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    Park, Kyong Hwa
    CANCER RESEARCH AND TREATMENT, 2014, 46 (02): : 172 - 177
  • [49] Second-line nab-paclitaxel for advanced urothelial carcinoma
    Sarah Payton
    Nature Reviews Urology, 2013, 10 (8) : 431 - 431
  • [50] Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma
    Lilenbaum, RC
    Schwartz, MA
    Seigel, L
    Belette, F
    Blaustein, A
    Wittlin, FN
    Davila, E
    CANCER, 2001, 92 (08) : 2158 - 2163
12345